Canara Robeco Asset Management Company Limited is launching a mainboard IPO on Oct 9–13, 2025, priced in the ₹253–₹266 band with a minimum lot of 56 shares, and the issue is a 100% Offer for Sale of 4.985 crore shares. IPO terms About the company Financials snapshot Status of filings and approvals How to apply […]
Incorporated in 1993, Canara Robeco Asset Management Company Limited serves as the investment manager to Canara Robeco Mutual Fund and operates as a joint venture of Canara Bank and ORIX Corporation Europe N.V., headquartered in Mumbai. Canara Robeco AMC IPO Mainboard book‑built issue (100% Offer for Sale) UPCOMING IPO IPO Window Oct 9 – Oct
Incorporated in 1999, Rubicon Research Limited develops, manufactures, and commercializes differentiated formulations across regulated markets. As of June 30, 2025, the portfolio includes 72 active ANDA/NDA approvals in the US with 66 commercialized products, alongside 17 pending ANDAs and 63 pipeline products under development. Rubicon Research IPO Mainboard book‑built issue (Fresh + Offer for Sale
Hella Infra Market Limited, better known as Infra.Market, has confidentially filed its draft red herring prospectus (DRHP) with SEBI for an IPO estimated at ₹4,500–₹5,500 crore, using the regulator’s pre‑filing route under Regulation 59C. Offer size and structure Banks and process Business and scale Recent funding and ownership What this means for investors Bottom line:
Vedanta Group’s Sterlite Electric Limited (formerly Sterlite Power Transmission) has filed its draft red herring prospectus (DRHP) with SEBI for an IPO comprising a fresh issue of 77.9 lakh shares and an equal‑sized OFS of 77.9 lakh shares, with market reports pegging the total raise near ₹1,500 crore depending on final pricing. Offer structure and
Ardee Industries Limited has filed its Draft Red Herring Prospectus (DRHP) with SEBI for an IPO comprising a ₹320 crore fresh issue and an Offer for Sale (OFS) of up to 3.76 crore equity shares by promoters, aiming to fund working capital, repay debt, and general corporate purposes. Offer structure and size Use of proceeds
LG Electronics India Ltd. opens its mainboard IPO on Oct 7–9, 2025 as a full Offer for Sale by the Korean parent, with a price band of ₹1,080–₹1,140 and a 13‑share lot; allotment is slated for Oct 10 and listing for Oct 14 on NSE and BSE. Below is a concise breakdown of key terms,
Tata Capital Limited opens its ₹15,511.87 crore mainboard IPO on Oct 6–8, 2025 with a price band of ₹310–₹326 and a 46‑share lot; allotment is slated for Oct 9 and listing for Oct 13 on NSE and BSE. Here is a concise breakdown of key terms, business context, and how to check allotment. Key IPO
Ganesh Consumer Products’ ₹408.8 crore mainboard IPO closes today with a slow retail build but improving institutional demand into the afternoon; GMP has stayed modest as books firmed up. Here are the latest Day‑3 subscription snapshots, today’s GMP context, and the exact next steps for allotment and listing. Day‑3 subscription snapshot GMP today Key dates
Atlanta Electricals’ ₹687.34 crore mainboard IPO closes today with strong demand led by NIIs and solid traction from retail and QIBs; GMP has stayed supportive into the final session. Here are the time‑stamped Day‑3 subscription snapshots, today’s GMP context, and the exact next steps for allotment and listing. Day‑3 subscription snapshot GMP today Allotment and
Purple Style Labs (PSL), parent of Pernia’s Pop‑Up Shop, has filed its draft red herring prospectus (DRHP) with SEBI to raise ₹660 crore via an all‑fresh issue with no OFS, targeting listings on NSE and BSE. The draft lays out a pre‑IPO placement option, detailed use of proceeds, and expanding omni‑channel plans. Offer structure and
Medicap Healthcare Ltd. has filed its draft red herring prospectus (DRHP) with SEBI for a ₹240 crore IPO comprised entirely of a fresh issue, with no offer‑for‑sale component. The draft outlines use of proceeds, potential pre‑IPO placement, and listing plans on BSE and NSE. Offer structure and size Use of proceeds Business overview Vadodara‑based Medicap
